Search Results

You are looking at 61 - 70 of 763 items for :

Clear All
Full access

Kuan-Ling Kuo, David Stenehjem, Frederick Albright, Saurabh Ray and Diana Brixner

ablation, resection, transplant, embolization, and radiation. Chemotherapy use was obtained from linked pharmacy records within the EDW. Date and cause of death were obtained from the UPDB. Survival and treatments were evaluated on the date of diagnosis

Full access

Stephanie L. Lee

/print certificate. Learning Objectives Upon completion of this activity, participants will be able to: Examine common acute and long-term adverse events associated with radioactive iodine Identify and construct effective management plans for

Full access

Daniel R. Simpson, Parag Sanghvi and Ajay P. Sandhu

/print certificate. Release date: November 4, 2014; Expiration date: November 4, 2015 Learning Objective Upon completion of this activity, participants will be able to: Explain the benefits of SBRT for patients with a prior pneumonectomy As of

Full access

Peter E. Clark

, these studies were able to validate each other's findings. In many ways, they have reshaped the entire framework by which we view the molecular drivers of urothelial carcinoma. Furthermore, although this work is not ready for clinical use yet, the

Full access

Denise Leung, Xiaosi Han, Tom Mikkelsen and L. Burt Nabors

/print certificate. Release date: November 4, 2014; Expiration date: November 4, 2015 Learning Objectives Upon completion of this activity, participants will be able to: Describe the challenges of MRI assessment in patients receiving bevacizumab

Full access

Jonathan M. Loree and Scott Kopetz

to study uncommon situations. By harnessing the strengths of studying entire populations rather than just focusing on patients enrolled on a trial, we may be able to answer difficult questions. For example, there are 8 patients with KRAS A59T

Full access

Arti Hurria

) understanding relevant information; 2) appreciating the medical situation in light of one’s underlying values; 3) using reason to make a decision; and 4) being able to communicate that choice. 7 If these components are met, the individual has the capacity to

Full access

hospitals and 780,000 physicians in America will be able to function as Medicare ACOs in the Health Reform legislation is becoming clear. The Centers for Medicare & Medicaid Services (CMS) projects that only 75 to 150 organizations in the country will be

Full access

Jessica K. DeMartino

biosimilarity to a reference product based on data derived from analytical studies, animal studies, and clinical studies. To determine and assess biosimilarity, analytical techniques must be able to examine primary sequences, secondary and tertiary structures

Full access

Margaret Tempero

, more transparent process for this, too. This has also been a long fight for our colleagues in gastroenterology. For 2 years now, they have been able to stall plans to cut reimbursement for this critical set of procedures. Fortunately, there is still